Production and characterization of a recombinant anti-MUC1 scFv reactive with human carcinomas.

por Denton, G., Sekowski, M., Spencer, D. I., Hughes, O. D., Murray, A., Denley, H., Tendler, S. J., Price, M. R.
Publicado 1997

Expression of miR-210 in relation to other measures of hypoxia and prediction of benefit from hypoxia modification in patients with bladder cancer

por Irlam-Jones, J J, Eustace, A, Denley, H, Choudhury, A, Harris, A L, Hoskin, P J, West, C M L
Publicado 2016

c-erbB-4 protein expression in human breast cancer

por Kew, T Y, Bell, J A, Pinder, S E, Denley, H, Srinivasan, R, Gullick, W J, Nicholson, R I, Blamey, R W, Ellis, I O
Publicado 2000

Expression of hypoxia-inducible factor-1α predicts benefit from hypoxia modification in invasive bladder cancer

por Hunter, B A, Eustace, A, Irlam, J J, Valentine, H R, Denley, H, Oguejiofor, K K, Swindell, R, Hoskin, P J, Choudhury, A, West, C M
Publicado 2014